PocketOS was left scrambling after a rogue AI agent deleted swaths of code underpinning its business It only took nine seconds for an AI coding agent gone rogue to delete a company’s entire production ...
Finland’s Kone has agreed to buy German rival TK Elevator in a landmark deal valued at 29.4 billion euros ($34.4 billion). The combination would create the world’s largest elevator maker and marks one ...
April 28 (Reuters) - Lift maker Kone (KNEBV.HE), opens new tab is nearing a cash-and-stock deal to buy German rival TK Elevator, valuing the company at about 29 billion euros ($33.97 billion), ...
FBI Director Kash Patel says a trip to Italy that raised questions earlier in 2026 helped set the stage for the arrest of a Chinese national accused of hacking U.S. COVID-19 research. Xu Zewei is now ...
Kone’s class B shares are listed on Nasdaq Helsinki Advent and Cinven acquired TKE in 2020 The transaction resets Kone’s current long-term financial targets A consortium, led by Advent and Cinven, has ...
A €29.4 billion ($34.4 billion) cash-and-stock agreement to purchase TK Elevator was announced Tuesday by Finnish manufacturer Kone, which said the combined entity would rank as the world's top ...
HELSINKI/GDANSK/FRANKFURT, May 4 (Reuters) - Brussels' antitrust rules have already once helped derail an attempt to create the world's top lift maker, but Kone's ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
HELSINKI, April 29 (Reuters) - Finnish lift maker Kone has agreed to buy ⁠German ⁠rival TK Elevator (TKE) in a deal worth 29.4 billion euros ($34.4 ⁠billion) that would create the world's largest lift ...
Since iOS 17 and iPadOS 17, Apple has included Messages-like reactions in FaceTime that lighten up your video with visual effects. But rather than triggering them with words, you can trigger them ...
A pandemic is a challenging but interesting moment for anyone involved in infectious disease, particularly those developing therapeutics and vaccines. That holds doubly true for Medicago, a Canadian ...